1. Wu X, Liu H, Xiao H, Conway JA, Kappes JC. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. J Virol. 1996;70(6):3378–84.
2. Tejerina F, Bernaldo de Quirós JC. Protease inhibitors as preferred initial regimen for antiretroviral-naive HIV patients. AIDS Rev. 2011;13:227–33.
3. EACS Guidelines. 2018. European AIDS Clinical Society.
http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html
.
4. DHHS, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2017. Department of Health and Human Services.
https://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL003510.pdf
. Accessed 4 June 2019.
5. Antinori A, Di Biagio A, Marcotullio S, Sarmati L, Andreoni M, Angarano G, et al. Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. New Microbiol. 2018;41(4):247–55.